[{"arm_notes": "", "treatment_id": null, "treatment_name": "The ravulizumab will be administered via IV infusion as below dosage regimen; In cae Patient Body Weight (kg) is 40 to 60; 2400mg at Day1; 600mg at at Day5 and Day10 and 900mg at Day15In cae Patient Body Weight (kg) is 60 to 100; 2700mg at Day1; 900mg at at Day5; Day10 and Day15In cae Patient Body Weight (kg) is over 100; 3000mg at Day1; 900mg at at Day5; Day10 and Day15", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1065, "treatment_name": "Ravulizumab", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1065, "treatment_name": "Ravulizumab", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1065, "treatment_name": "Ravulizumab", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "The ravulizumab will be administered via IV infusion as below dosage regimen; In cae Patient Body Weight (kg) is 40 to 60; 2400mg at Day1; 600mg at at Day5 and Day10 and 900mg at Day15In cae Patient Body Weight (kg) is 60 to 100; 2700mg at Day1; 900mg at at Day5; Day10 and Day15In cae Patient Body Weight (kg) is over 100; 3000mg at Day1; 900mg at at Day5; Day10 and Day15", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]